Skip to main navigation
Intercept Pharmaceuticals homepage
  • News
  • Contact Us
Intercept Pharmaceuticals Logo
Menu
Close✕
  • Our Focus
    • Rare and Serious Liver Diseases
      • Meet Ally
      • Racial Disparities in PBC
    • Patient Resources
  • Our Research
    • FXR
    • Pipeline
      • Expanded Access
    • Clinical Trials
    • Medical Information Request Form
  • Our Medicine
  • About Us
    • Leadership
    • News
    • Company Statements
  • Careers
    • Job Postings
    • Culture
    • US Benefits
  • Media
  • Contact Us
Home > Transparency Disclosures

    Transparency Disclosures

    Please refer below to transparency disclosures in local language and with English translation.

    Austria

    Belgium

    Canada

    Finland

    France

    Germany

    Ireland

    Italy

    Luxembourg

    The Netherlands

    Portugal

    Spain

    Sweden

    Switzerland

    United Kingdom


    Austria

    Cooperation with patient organizations
    Zusammenarbeit mit Patientenorganisationen

    Intercept supported the following patient organizations in Austria in the 2022 calendar year. The information is not final and is updated from time to time, usually annually.

    Intercept hat im Kalenderjahr 2022 folgende Patientenorganisationen in Österreich unterstützt. Die Informationen sind nicht endgültig und werden von Zeit zu Zeit, in der Regel jährlich, aktualisiert.

    Transparenz PTO Intercept 2022

    Intercept supported the following patient organizations in Austria in the 2021 calendar year. The information is not final and is updated from time to time, usually annually.

    Intercept hat im Kalenderjahr 2021 folgende Patientenorganisationen in Österreich unterstützt. Die Informationen sind nicht endgültig und werden von Zeit zu Zeit, in der Regel jährlich, aktualisiert.

    Transparenz PTO Intercept 2021

    Intercept supported the following patient organizations in Austria in the 2020 calendar year. The information is not final and is updated from time to time, usually annually.

    Intercept hat im Kalenderjahr 2020 folgende Patientenorganisationen in Österreich unterstützt. Die Informationen sind nicht endgültig und werden von Zeit zu Zeit, in der Regel jährlich, aktualisiert.

    Transparenz PTO Intercept 2020

    2022 Austria Transparency Disclosure
    2021 Austria Transparency Disclosure
    2020 Austria Transparency Disclosure


    Belgium

    Relations with patient associations
    Relatie met patiëntenverenigingen
    Relations avec les associations de patients
    Zusammenarbeit mit Patientenorganisationen

    Information regarding Intercept’s support for patient associations in Belgium can be found by consulting the Belgian transparency website (https://www.betransparent.be).

    Intercept’s ondersteuning van patiëntenorganisaties in België is te vinden in het Belgische transparantieplatform (https://www.betransparent.be).

    Les informations concernant le soutien d’Intercept aux associations de patients en Belgique peuvent être trouvées en consultant le site de la Transparence belge (https://www.betransparent.be).

    Intercepts Unterstützungen an Patientenorganisationen in Belgien finden Sie auf der Belgischen Transparenzplattform (https://www.betransparent.be).

    Intercept has supported the following patient organizations in Belgium during calendar year 2018. Information about this is subject to change and will be updated from time to time, usually once a year.

    Intercept heeft de volgende patiëntenverenigingen gesteund in België in het jaar 2018. Deze informatie kan veranderen en zal regelmatig bijgewerkt worden, gewoonlijk op jaarlijkse basis.

    Intercept a appuyé les associations de patients suivantes en Belgique pendant l’année civile 2018. Les informations à ce propos sont susceptibles de changer et seront mises à jour de temps à autre, généralement une fois par an.

    Intercept hat im Kalenderjahr 2018 folgende Patientenorganisationen in Belgien unterstützt. Die Informationen sind nicht endgültig und werden von Zeit zu Zeit, in der Regel jährlich, aktualisiert.

    Patiëntenvereniging
    Bedrag
    Doel van de betaling
    European Liver Patients' Association€7,200 Financiële ondersteuning voor standruimte op de EASL NAFLD Summit in september 2018.
    Association de patients
    Montant
    Objet du paiement
    European Liver Patients' Association€7,200 Soutien financier pour le stand réservé lors du congrès EASL NAFLD de septembre 2018.
    Patientenorganisation
    Betrag
    Verwendungszweck
    European Liver Patients' Association€7,200 Finanzielle Unterstützung für Standflächen beim EASL NAFLD-Gipfel im September 2018.

    Canada

    Not applicable.


    Finland

    Relations with patient organizations
    Suhteet potilasjärjestöihin

    During the calendar year 2019, Intercept supported the following patient organizations located in Finland. The information may change and may therefore be updated from time to time, typically annually.

    Intercept tuki kalenterivuoden 2019 aikana seuraavia Suomessa sijaitsevia potilasjärjestöjä. Tiedot saattavat muuttua, ja niitä voidaan päivittää sen vuoksi ajoittain, tyypillisesti vuosittain.

    Potilasjärjestö
    Määrä
    Maksun tarkoitus
    The Finnish Kidney & Liver Association

    Munuais- Ja Maksaliitto

    €5.000Vuoden 2019 Maksaviikolle osoitettu tuki.
    The Finnish Kidney & Liver Association

    Munuais- Ja Maksaliitto

    €5.000 The European Association for the Study of the Liver (EASL) - järjestön sappikirroosia sairastaville potilaille laatiman potilasohjeen kääntämiseen osoitettu apuraha.

    During the calendar year 2018, Intercept supported the following patient organizations located in Finland. The information may change and may therefore be updated from time to time, typically annually.

    Intercept tuki kalenterivuoden 2018 aikana seuraavia Suomessa sijaitsevia potilasjärjestöjä. Tiedot saattavat muuttua, ja niitä voidaan päivittää sen vuoksi ajoittain, tyypillisesti vuosittain.

    Potilasjärjestö
    Määrä
    Maksun tarkoitus
    The Finnish Kidney and Liver Association€10.000 Lisääntyvä tietoisuus maksasairaudesta Suomessa antamalla apurahaa maksuviikolle 2018, johon kuuluu julkisia luentoja ja sairaanhoitajien koulutuspäivää

    During the calendar year 2017, Intercept supported the following patient organizations located in Finland. The information may change and may therefore be updated from time to time, typically annually.

    Intercept tuki kalenterivuoden 2017 aikana seuraavia Suomessa sijaitsevia potilasjärjestöjä. Tiedot saattavat muuttua, ja niitä voidaan päivittää sen vuoksi ajoittain, tyypillisesti vuosittain.

    Potilasjärjestö
    Määrä
    Maksun tarkoitus
    The Finnish Kidney and Liver Association - Suomen maksa ja munuais- Liitto €914 Matka- ja majoituskulut PBC potilasverkoston tapaamisessa 2.3.2017 Amsterdam, Hollanti.

    Individual transfers of value to treatment service providers and healthcare organizations
    Yksittäiset arvonsiirrot hoitopalvelujen tarjoajille ja terveydenhuollon organisaatioille

    We disclose these costs as required by the Medicines Act.
    Paljastamme nämä kulut lääkelain edellyttämällä tavalla.

    2019 Finland Transparency Disclosure

    2018 Finland Transparency Disclosure

    2017 Finland Transparency Disclosure


    France

    Access the Transparency-Health public database.
    Accéder à la base de données publique Transparence - Santé.


    Germany

    Cooperation with patient organizations
    Zusammenarbeit mit Patientenorganisationen

    Intercept supported the following patient organizations in Germany in the 2022 calendar year. The information is not final and is updated from time to time, usually annually.

    Intercept hat im Kalenderjahr 2022 folgende Patientenorganisationen in Deutschland unterstützt. Die Informationen sind nicht endgültig und werden von Zeit zu Zeit, in der Regel jährlich, aktualisiert.

    Patientenorganisation
    Betrag
    Verwendungszweck
    Berliner Leberring e.V.€1.500 Sponsorship Berliner Leberring Jubiläumsveranstaltung
    Kautz5 gUG€12.500 Broschüre für PBC Betroffene und deren Angehörige auf der inhaltlichen
    Basis der PBC-Onlinereihe 2021
    Kautz5 gUG€10.500Update der Website pbcnews.info
    Kautz5 gUG€211.598 Organisation Patienten Workshop (inklusive Reisekosten)

    Intercept supported the following patient organizations in Germany in the 2021 calendar year. The information is not final and is updated from time to time, usually annually.

    Intercept hat im Kalenderjahr 2021 folgende Patientenorganisationen in Deutschland unterstützt. Die Informationen sind nicht endgültig und werden von Zeit zu Zeit, in der Regel jährlich, aktualisiert.

    Patientenorganisation
    Betrag
    Verwendungszweck
    Deutsche Gesellschaft für Gastroenterologie €368Abonnement Lebenszeichen 2021
    Deutsche Gesellschaft für Gastroenterologie €5.000Zuwendung Baisis mini 2021
    Leberhilfe Projekt gUG€3.367 Entwurf und Unterstützung für Expertengruppe Patientenumfrage
    Leberhilfe Projekt gUG€360Honorare
    Leberhilfe Projekt gUG€5.700Unterstützung für Website pbcnews.info
    Leberhilfe Projekt gUG€12.0002021 Patientenschulungsseminare - März
    Leberhilfe Projekt gUG€10.0002021 Patientenschulungsseminare - Mai
    Leberhilfe Projekt gUG€10.000 2021 Patientenschulungsseminare - September

    Intercept supported the following patient organizations in Germany in the 2020 calendar year. The information is not final and is updated from time to time, usually annually.

    Intercept hat im Kalenderjahr 2020 folgende Patientenorganisationen in Deutschland unterstützt. Die Informationen sind nicht endgültig und werden von Zeit zu Zeit, in der Regel jährlich, aktualisiert.

    Patientenorganisation
    Betrag
    Verwendungszweck
    Deutsche Leberhilfe e.V.€5.000 Unterstützung der Vereinstätigkeiten und -veranstaltungen zur Untertützung von Leberpatienten
    Leberhilfe Projekt gUG€31.330 Online Runde Tische mit PBC Patienten und MFAs
    Leberhilfe Projekt gUG€300 Patientenvideo anlässlich INTL NASH Day
    Leberhilfe Projekt gUG€12.850NASH Film: Versorgungsmodell
    Leberhilfe Projekt gUG€270DACH NASH Policy Forum Moderation
    Leberhilfe Projekt gUG€9.831,75P2P Projektfinanzierung
    Leberhilfe Projekt gUG€951NASH Patient Expert Meeting, Berlin

    Disclosure of Payments to Healthcare Professionals and Healthcare Organizations
    Offenlegung von Zahlungen an Angehörige im Gesundheitswesen und Gesundheitsorganisationen

    In accordance with the AKG Transparency Code, Intercept discloses all individual donations of value to physicians and healthcare organizations. Reporting is in the respective national language. Please note that there may be slight discrepancies in the disclosure of figures on this page compared to other sources. Further explanations can be found in the methodological notes.

    In Übereinstimmung mit dem AKG-Transparenzkodex legt Intercept alle individuellen geldwerten Zuwendungen an Ärzte und Organisationen des Gesundheitswesens offen. Die Berichterstattung erfolgt in der jeweiligen Landessprache. Bitte beachten Sie, dass es zu geringfügigen Unterschieden zwischen der Offenlegung der Zahlen auf dieser Seite im Vergleich zu anderen Quellen kommen kann. Weitere Erläuterungen befinden sich in den Methodischen Hinweisen.

    2022 Intercept Germany Transparency Disclosure
    2022 Intercept Germany Transparency Methodology

    2021 Intercept Germany Transparency Disclosure
    2021 Intercept Germany Transparency Methodology

    2020 Intercept Germany Transparency Disclosure
    2020 Intercept Germany Transparency Methodology


    Ireland

    Not applicable.


    Italy

    Not applicable.


    Luxembourg

    Not applicable.


    The Netherlands

    Support patient associations
    Ondersteuning patiëntenverenigingen

    Intercept’s support for patient organizations for 2019 in the Netherlands can be found in the Transparency Register (https://www.transparantieregister.nl/nl-nl/home).

    Intercept’s ondersteuning van patiëntenorganisaties voor 2019 in Nederland is te vinden in het Transparantieregister (https://www.transparantieregister.nl/nl-nl/home).

    Intercept provided support for the following patient associations based in the Netherlands during calendar year 2018. The information is subject to change and will be updated from time to time, usually on an annual basis.

    Intercept verleende ondersteuning voor de volgende patiëntenverenigingen die in Nederland zijn gevestigd tijdens kalenderjaar 2018. De informatie is onderhevig aan verandering en zal van tijd tot tijd worden bijgewerkt, meestal op jaarbasis.

    Patiëntenvereniging
    Bedrag
    Ondersteunde activiteiten
    Nederlandse Leverpatiënten Vereniging€3,500.00 Financiële ondersteuning voor het vertalen, aanpassen en creëren van Nederlandse PBC-Patiënt Richtlijnen gebaseerd op de EASL PBC-Patiënt Richtlijnen
    Nederlandse Leverpatiënten Vereniging€5,000.00 Financiële ondersteuning voor het ontwikkelen en uitbrengen van een brochure voor huisartsen over PBC en de "do's" en "don'ts" aangaande mensen met PBC
    Nederlandse Leverpatiënten Vereniging€150.32 Honorarium voor presenteren op de EASL PBC Netwerk Vergadering

    Intercept provided support for the following patient associations located in the Netherlands during calendar year 2017. The information is subject to change and will be updated from time to time, usually on an annual basis.

    Intercept verleende ondersteuning voor de volgende patiëntenverenigingen die in Nederland zijn gevestigd tijdens kalenderjaar 2017. De informatie is onderhevig aan verandering en zal van tijd tot tijd worden bijgewerkt, meestal op jaarbasis.

    Patiëntenvereniging
    Bedrag
    Ondersteunde activiteiten
    Nederlandse Leverpatiënten Vereniging€550 Vertaling naar het Engels van de stigmavideo ‘Leverpatiënten zijn het zat’
     €2,500 PBC-consortium: belangenbehartiging, patiëntondersteuning en delen van informatie
     €3,000PBC-consortium vergadering
     €3,000Testgroep voor patiëntenmaterialen
     €1,000 NASH-consortium: belangenbehartiging en delen van informatie
    Nederlandse Leverpatiënten Vereniging namens het EU PBC Patient Network €30,000 Ondersteuning voor het organiseren van de International PBC Day campagne in natura door middel van het aanbieden van diensten door een agentschap

    2019 Netherlands Transparency Disclosure - R&D
    2018 Netherlands Transparency Disclosure – R&D
    2017 Netherlands Transparency Disclosure – R&D


    Portugal

    Relationship with Patient Associations
    Relacionamento com as Associações de Doentes

    In 2018, no support was granted to patient associations in Portugal.

    No ano de 2018 não foi concedido nem pao qualquer apoio a associações de doentes em Portugal.

    Intercept provided support to the following patient organizations in Portugal during 2017. This information, subject to change, will be updated periodically, normally once a year.

    A Intercept disponibilizou apoio à(s) seguinte(s) associações de doentes, em Portugal, durante o ano de 2017, Esta informação, passível de ser alterada, será actualizada periodicamente, normalmente uma vez por ano.

    Associação de doentes
    Valor
    Motivo do Apoio
    Rarissimas-Associação Nacional Deficiencias Mentais e Raras €14,500.00 Grant para o Projecto CBP -Cidadania Rara- tradução de vídeo de CBP, desenvolvimento e produção de guia de bolso, gravação de um curso de treino em CBP, e custos de viagem e alojamento.
    Rarissimas-Associação Nacional Deficiencias Mentais e Raras €643.00 Viagens e acomodação, para a participação no “PBC Patient Network Meeting”, que teve lugar a 2 de Março de 2017, em Amsterdão, Holanda

    Intercept provided support to the following patient organizations in Portugal during 2016. This information, subject to change, will be updated periodically, normally once a year.

    A Intercept disponibilizou apoio à(s) seguinte(s) associações de doentes, em Portugal, durante o ano de 2016, Esta informação, passível de ser alterada, será actualizada periodicamente, normalmente uma vez por ano.

    Associação de doentes
    Valor
    Motivo do Apoio
    Rarissimas-Associação Nacional Deficiencias Mentais e Raras €20,810 Apoio relativo ao prémio Practice to Policy, para a Europa e Canadá, com que a Raríssimas foi distinguida pelo seu projecto de informação sobre a doença (IN)Forma Rara.
    Rarissimas-Associação Nacional Deficiencias Mentais e Raras €724 Apoio relativo aos custos associados à participação de dois representantes da Raríssimas num Advisory Board sobre a rede Europeia de CBP.
    Rarissimas-Associação Nacional Deficiencias Mentais e Raras €4,600 Apoio dado através do trabalho de uma agência de comunicação que colaborou com a Rarissimas em actividades relacionadas com a comunicação associada ao Dia Mundial da CBP e do prémio Practice to Policy relativo ao projecto (IN)Forma Rara.

    Spain

    Not applicable.


    Sweden

    Open reporting of value transfers from 2019 for healthcare professionals (HCPs), healthcare providers (HCOs) and patient associations can be found in the LIF collaboration database (https://www.lif.se/etik/samarbetsdatabaser/).

    Öppen rapportering av värdeöverföringar från 2019 för Hälso- och sjukvårdspersonal (HCP):er, hälso- och sjukvård (HCO):er och patientföreningar finns i LIF-samarbetsdatabasen (https://www.lif.se/etik/samarbetsdatabaser/).

    Relationship with Patient Organisations
    Relation med Patientorganisationer

    Intercept has provided support to the following Swedish patient organizations in 2018. The information may change and will be updated on an annual basis.

    Intercept har gett stöd till följande svenska patientorganisationer 2018. Informationen kan komma att ändras och kommer att uppdateras på årlig bas.

    Patient Förening
    Belopp
    Syfte
    PBCSverigeSEK 11,232 Stipendium för PBC patient mötet i Stockholm

    Intercept has provided support to the following Swedish patient organizations in 2017. The information may change and will be updated on an annual basis.

    Intercept har gett stöd till följande svenska patientorganisationer 2017. Informationen kan komma att ändras och kommer att uppdateras på årlig bas.

    Patientorganisation
    Belopp
    Syfte
    Renata Brucker-PrivatkontoSEK 1,439 Pbc-föreningen i Sverige c/o Brucker, Smedbyvägen 26 184 32 Åkersberga, Sverige

    2018 Intercept Sweden Transparency Disclosure
    2018 Intercept Sweden Transparency Methodology


    Switzerland

    Not applicable.


    United Kingdom


    Relationships with Patient Organizations and the Public

    In accordance with the ABPI Code of Conduct, Intercept discloses all payments to patient organizations and members of the public, including patients and journalists. The information is subject to change and will be updated accordingly from time to time, typically on an annual basis. Further explanation can be found in the methodological note below.

    2022 PAG Transparency Disclosure

    2022 PAG Transparency Disclosure Methodology

    2021 PAG Transparency Disclosure

    2021 PAG Transparency Disclosure Methodology

    Summary of collaborative working agreement with PBC Foundation UK

    Intercept provided support for the following patient organizations based in the UK during calendar year 2020. The information is subject to change and will be updated accordingly from time to time, typically on an annual basis.

    Patient Organization
    Amount
    Purpose of Payment
    British Liver Trust£1,800 Support for the design & support to complete a Patient Survey Expert Group.
    British Liver Trust£150Support for patient interviews.
    British Liver Trust£20,000 Grant to support the core activities of the British Liver Trust.
    British Liver Trust£13,500 Collaboration to work in partnership for action on NASH policy.
    Liver4Life£93.50Support to travel to P2P Summit.
    PBC Foundation£1,410 Honoraria for being a Practice to Policy Programme judge representative.
    PBC Foundation£9,758 Grant to support the delivery of digital services during Covid-19.
    PBC Foundation£25,000 Grant to support the core activities of the PBC Foundation.

    Disclosures are made in local currency (GBP). Where payments are made in foreign currency, these have been converted to GBP using the exchange rate applied by our Finance team for the month in which the payment was made.

    • Our Focus
      • Rare and Serious Liver Diseases
        • Meet Ally
        • Racial Disparities in PBC
      • Patient Resources
    • Our Research
      • FXR
      • Pipeline
        • Expanded Access
      • Clinical Trials
      • Medical Information Request Form
    • Our Medicine
    • About Us
      • Leadership >
      • News >
    • Careers
      • Job Postings
      • Culture
      • US Benefits
    Intercept Pharmaceuticals Logo
    • Website Privacy Policy
    • Consumer Health Data Privacy Policy
    • EU-US Data Privacy Framework (DPF) Policy
    • Corporate Compliance
    • Terms of Use
    • Contact Us
    • Cookie Preferences
    • Transparency Disclosures
    305 Madison Avenue |Morristown, NJ 07960|T: (844) 782–4278
    © 2024 Intercept Pharmaceuticals, Inc.
    US-NP-N/A-0232
    US-NP-N/A-0232

    YOU ARE NOW leaving interceptpharma.com


    You are now leaving Intercept Pharmaceuticals’ corporate website and entering a site intended for U.S. audiences only.

    Continue

    YOU ARE NOW leaving interceptpharma.com


    You are now leaving Intercept Pharmaceuticals’ corporate website. Intercept does not control or endorse the content of this external site.

    Continue

    YOU ARE NOW leaving interceptpharma.com


    The link you have selected will take you outside of Intercept Pharmaceuticals’ corporate website.
    The site you will be entering is intended for U.S. audiences only.

    Continue


    If you are a healthcare provider looking for product information, visit ocalivahcp.com.

    YOU ARE NOW leaving interceptpharma.com


    You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents. Intercept provides this link as a service to its website visitors. Intercept is not responsible for the content or the privacy policy of any third party websites.

    Close this window to return to Intercept Pharmaceuticals’ site or click ‘Continue’ to proceed.

    Continue

    United States (US)
    European Union (EU)
    Canada
    Israel
    Switzerland
    Australia
    Liechtenstein
    United Arab Emirates (UAE)

    Close

    Exploring Racial Differences and Disparities in PBC Care